A recent study showed that interaction between the immune system and the gut microbiota plays a crucial role in the development of MS. This episode includes a discussion with Dr. Emmanuelle Waubant regarding her ongoing research and new treatments for multiple sclerosis (MS). Dr. Waubant is the Director of UCSF Regional Pediatric Multiple Sclerosis Center and serves on the clinical care committee of the National Multiple Sclerosis Society's local chapter and the translational research review committee for the society's national office.
Read Transcript
CME Information: https://stanford.cloud-cme.com/medcastepisode42
Claim CE: https://stanford.cloud-cme.com/Form.aspx?FormID=1194
This CME Activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
Episode 5: COVID-19 Mini-series - Immunomodulators under evaluation
Episode 4: COVID-19 Mini-series - A Brief Overview of Monoclonal Antibodies
Episode 3: COVID-19 Mini-series - Pain Management
Episode 2: COVID-19 Mini-series - Multisystem Inflammatory Syndrome in Children
Episode 1: COVID-19 Mini-series - Management of Diabetes patients in COVID
Episode 0: Stanford Medcast Trailer
Create your
podcast in
minutes
It is Free
Navigating Life After 40
Teaching Learning Leading K-12
Regenerative Skills
The Jordan B. Peterson Podcast
The Mel Robbins Podcast